Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung CancerMarina Pekar‐Zlotin(Tel Aviv University), Nir Peled(Tel Aviv University)The OncologistFebruary 26, 201510.1634/theoncologist.2014-0389Cited by 146SaveCiteExport RISWatch citationsRelated PapersNext-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer|Journal of Thoracic Oncology|2012|132